User profiles for "author:L Fabbri"
Leonardo M. FabbriUniversità di Ferrara Verified email at unife.it Cited by 74211 |
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary
Chronic obstructive pulmonary disease (COPD) is a global health problem, and since 2001,
the Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published its strategy …
the Global Initiative for Chronic Obstructive Lung Disease (GOLD) has published its strategy …
Standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults
PJ Sterk, LM Fabbri, PH Quanjer… - European …, 1993 - Eur Respiratory Soc
Asthma and chronic obstructive pulmonary disease (COPD, also called chronic airflow
limitation (CAL)) are the most frequent diagnoses in patients with intrathoracic airways ob …
limitation (CAL)) are the most frequent diagnoses in patients with intrathoracic airways ob …
[HTML][HTML] Cellular and structural bases of chronic obstructive pulmonary disease
M Saetta, G Turato, P Maestrelli, CE Mapp… - American journal of …, 2001 - atsjournals.org
Chronic obstructive pulmonary disease (COPD) is defined as a disease state characterized
by poorly reversible airflow limitation that is usually both progressive and associated with an …
by poorly reversible airflow limitation that is usually both progressive and associated with an …
Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary
CF Vogelmeier, GJ Criner, FJ Martinez… - American journal of …, 2017 - atsjournals.org
This Executive Summary of the Global Strategy for the Diagnosis, Management, and
Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 …
Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 …
Chronic obstructive pulmonary disease phenotypes: the future of COPD
Significant heterogeneity of clinical presentation and disease progression exists within
chronic obstructive pulmonary disease (COPD). Although FEV1 inadequately describes this …
chronic obstructive pulmonary disease (COPD). Although FEV1 inadequately describes this …
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations
A Papi, CM Bellettato, F Braccioni… - American journal of …, 2006 - atsjournals.org
Rationale: Severe exacerbations of chronic obstructive pulmonary disease (COPD) are
major causes of health care costs mostly related to hospitalization. The role of infections in …
major causes of health care costs mostly related to hospitalization. The role of infections in …
American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias
Despite the considerable progress in the classification of the idiopathic interstitial
pneumonias (IIPs), the lack of an international standard has resulted in variable and …
pneumonias (IIPs), the lack of an international standard has resulted in variable and …
CD8+ T-Lymphocytes in Peripheral Airways of Smokers with Chronic Obstructive Pulmonary Disease
M Saetta, A Di STEFANO, G Turato… - American journal of …, 1998 - atsjournals.org
To investigate whether the inflammatory process in peripheral airways is different in smokers
who develop symptoms of chronic bronchitis and chronic airflow limitation and in …
who develop symptoms of chronic bronchitis and chronic airflow limitation and in …
Complex chronic comorbidities of COPD
LM Fabbri, F Luppi, B Beghé… - European Respiratory …, 2008 - Eur Respiratory Soc
Chronic obstructive pulmonary disease (COPD) is defined by fixed airflow limitation
associated with an abnormal pulmonary and systemic inflammatory response of the lungs to …
associated with an abnormal pulmonary and systemic inflammatory response of the lungs to …
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials
PMA Calverley, KF Rabe, UM Goehring, S Kristiansen… - The Lancet, 2009 - thelancet.com
Background The phosphodiesterase-4 inhibitor roflumilast can improve lung function and
prevent exacerbations in certain patients with chronic obstructive pulmonary disease …
prevent exacerbations in certain patients with chronic obstructive pulmonary disease …